/PRNewswire/ Curative Biotechnology, Inc. (OTC: CUBT) ("Curative Biotech" or the "Company") announced today that the Company has reached agreement with.
Share this article
BOCA RATON, Fla., April 29, 2021 /PRNewswire/
Curative Biotechnology, Inc. (OTC: CUBT) a development stage biomedical company focused on novel therapies for rare diseases, announced today the Company s trading symbol change from CTYX to CUBT . As previously announced, the Company had changed its corporate name to Curative Biotechnology, Inc. to better represent its mission to discover and develop therapeutics for patients who have few, if any, effective treatments for rare diseases.
Curative Biotechnology Inc. Chairman and President Paul Michaels said, This name and symbol change are reflective of our total remaking of this company and our mission to create treatments or cures for unmet medical needs for patients around the world.